vimarsana.com
Latest Breaking News On - Henno welgemoed - Page 1 : vimarsana.com
FDA Grants Orphan Drug Designation to PTX-252 for AML
The FDA has granted an orphan drug designation to PTX-252 for the treatment of patients with acute myeloid leukemia.
Henno-welgemoed
Stijn-van-rompay
Ivo-timmermans
Hyloris-pharmaceuticals
Van-rompay
Pleco-therapeutics
Orphan-drug-designation
Hematology
Aml
Acute-myeloid-leukemia
Ptx-252-
Ptx-252-in-aml
Pleco Therapeutics Announces the Appointment of Dr. Henno Welgemoed as Chief Medical Officer
NIJMEGEN, Netherlands, Sept. 05, 2023 (GLOBE NEWSWIRE) Pleco Therapeutics BV, a specialty pharmaceutical company developing novel Plecoid™ therapies designed to detoxify the cancer microenvironment, today
New-jersey
United-states
Netherlands
United-kingdom
South-africa
Pretoria
Gauteng
Newark
Nijmegen
Gelderland
Ivo-timmermans
Henno-welgemoed
vimarsana © 2020. All Rights Reserved.